FOLH1 and central nervous system cancer: In a pilot study by Verma et al. [19], 10 patients with suspected gliomas underwent both [68Ga]Ga-PSMA-11 and [18F]FDG PET/CT (1 to 5 days apart), revealing PSMA expression in all patients.